IMPAKT 2017

Oncology Meeting Resources

04 May - 06 May 2017, Brussels, Belgium

IMPAKT 2017 breast cancer conference

IMPAKT 2017 Breast Cancer Conference was designed for breast cancer researchers and clinicians who have a specific interest in translational research, new agents, molecular and functional diagnostics, biomarkers and cutting-edge research applications in the clinical setting.

Resources from IMPAKT 2017 Breast Cancer Conference are available to ESMO member according to the presenters' agreement to release them. The use of these presentations is for personal educational purposes only. ESMO and BIG thank the authors for their generosity.

Download the IMPAKT 2017 Scientific report

ESMO Scientific videos from IMPAKT 2017

Useful links





Format available

http://oncologypro.esmo.org/Meeting-Resourc...nd-results-from-the-BIG-2-98-phase-III-trial

BodyPurpose: To gain better insight into the prognostic role of the STAT3 signaling pathway in estrogen receptor positive (ER positive) breast cancer, we evaluated the pSTAT3 proteomic and gene signature...

Date: 04 May 2017
Presenter: Amir Sonnenblick
Resources: Abstract
Topics: Breast Cancer, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...-of-RANKL-and-OPG-and-breast-cancer-survival

BodyIntroduction: Experimental data suggest Receptor Activator of Nuclear Factor Kappa-B ligand (RANKL) and its decoy receptor Osteoprotegerin (OPG) play an important role in mammary tumor development and progression.

Date: 04 May 2017
Presenter: Danja Sarink
Resources: Abstract, Presentation, Webcast
Topics: Biomarkers, Breast Cancer, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...17/Invited-discussant-abstracts-3O-4O-and-5O

Date: 04 May 2017
Presenter: Sabine Linn
Resources: Presentation, Webcast
Topic: Breast Cancer

http://oncologypro.esmo.org/Meeting-Resourc...-HER2-ABC-Efficacy-by-baseline-tumor-markers

BodyBackground: Cyclin D–cyclin-dependent kinase (CDK) 4/6 complexes promote cell proliferation through retinoblastoma protein (Rb) phosphorylation. Cyclin D gene (CCND1) amplification or loss of...

Date: 04 May 2017
Presenter: Fabrice André
Resources: Abstract
Topics: Breast Cancer, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...-2017/Invited-discussant-abstracts-1O-and-2O

Date: 04 May 2017
Presenter: Philippe Bedard
Resources: Presentation, Webcast
Topic: Breast Cancer

http://oncologypro.esmo.org/Meeting-Resourc...ed-by-lateral-magnetophoretic-microseparator

BodyCTCs get a lot of attention because provide genetic information that enables monitoring of the evolution of cancer and selection of therapeutic strategies that cannot be obtained from tumor biopsy....

Date: 04 May 2017
Presenter: Hyungseok Cho
Resources: Abstract
Topics: Breast Cancer, Imaging, Diagnosis and Staging, Pathology/Molecular Biology

http://oncologypro.esmo.org/Meeting-Resourc...tumor-cells-CTCs-in-metastatic-breast-cancer

BodyThe presence of circulating tumor cells (CTCs) in the blood of patients with breast cancer is by now a well-recognized prognosticator for poor prognosis but the selection of systemic therapy based...

Date: 04 May 2017
Presenter: Kristina Aaltonen
Resources: Abstract
Topics: Breast Cancer, Imaging, Diagnosis and Staging

http://oncologypro.esmo.org/Meeting-Resourc...ating-Tumor-Cells-by-Microfluidic-Technology

BodyThis paper introduces a single-cell isolation microfluidic device for isolating circulating tumor cells from peripheral blood. CTCs from blood are first separated by lateral magnetophoresis.

Date: 04 May 2017
Presenter: Jinho Kim
Resources: Abstract
Topics: Breast Cancer, Imaging, Diagnosis and Staging, Pathology/Molecular Biology

http://oncologypro.esmo.org/Meeting-Resourc...ancer-Observations-from-a-single-institution

BodyPurpose: Recent developments in the treatment for early bone metastases (BM) requires better understanding of the metastatic distribution, incidence, and timing of bone metastases, as it may be...

Date: 04 May 2017
Presenter: Mark Wickre
Resources: Abstract
Topics: Breast Cancer, Imaging, Diagnosis and Staging

http://oncologypro.esmo.org/Meeting-Resourc...2017/Epidemiology-of-Breast-Cancer-among-Men

BodyBackground: Breast cancer is a public health problem in Algeria; it's the first location in women: 54 new case/100,000women (INSP Algiers 2012),but it remains a rare location in men and there is no study on the subject.

Date: 04 May 2017
Presenter: Asma Boudersa
Resources: Abstract
Topics: Breast Cancer, Imaging, Diagnosis and Staging